Directory
>
Michael Jones
Michael Jones
CFO | Recor Medical
San Jose, California, United States
Michael Jones
Summary
Michael Jones is a seasoned CFO with a robust track record in financial leadership across diverse industries, including medical equipment and commercial research. His career spans over two decades, during which he has held key positions at notable companies such as Yahoo, Varian Medical Systems, and Cytek Biosciences. Michael's expertise encompasses a wide range of financial disciplines, including strategic planning, SEC reporting, and acquisition integration. He is known for his ability to drive business transformation and enhance financial operations, evidenced by his successful leadership in IPO preparations and ERP migrations. With a global perspective, having worked across North America, Europe, and Asia-Pacific, he brings a unique understanding of international finance dynamics. Michael is a certified CPA (inactive) and holds an MBA from the University of Louisiana at Lafayette, demonstrating his commitment to continuous professional development. His forward-thinking approach positions finance as a strategic partner in business growth.
Michael Jones
Work Experience
CFO at
Recor Medical
June 2023 - Present
CFO/COO at
SENSE BIODETECTION LIMITED
March 2022 - July 2023
VP, Finance at
Cytek Biosciences
January 2020 - March 2022
SVP, Global FP&A at
Varian
January 2017 - January 2018
VP Finance/Division CFO, Oncology Business Unit at
Varian
September 2012 - December 2016
Corporate Controller at
HGST, a Western Digital brand
May 2010 - September 2012
VP, Americas Controller at
Yahoo
January 2007 - May 2010
Sr, Director, Accounting Services at
Yahoo
January 2004 - January 2007
Assistant U.S. Controller, and Previous Roles at
Nortel Networks
August 1998 - January 2004
Michael Jones
Education
University of Louisiana at Lafayette, Master Of Business Administration - Mba
January 1992 - January 1993
Tulane University, Bachelor Of Science - Bs
January 1987 - January 1992
Frequently Asked Questions about Michael Jones
What is Michael Jones email address?
Michael Jones's primary email address is ******@recormedical.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Jones work for?
Michael Jones is a CFO at Recor Medical, a company specializing in Medical Equipment & Supplies Manufacturing.
Where Michael Jones graduated from?
Michael Jones holds a degree in from University of Louisiana at Lafayette.
How can I directly contact Michael Jones?
To contact Michael Jones directly, you can use the email address ******@recormedical.com. Complete contact information is available upon registration with Muraena.
Who is Michael Jones?
Michael Jones is a seasoned CFO with a robust track record in financial leadership across diverse industries, including medical equipment and commercial research. His career spans over two decades, during which he has held key positions at notable companies such as Yahoo, Varian Medical Systems, and Cytek Biosciences. Michael's expertise encompasses a wide range of financial disciplines, including strategic planning, SEC reporting, and acquisition integration. He is known for his ability to drive business transformation and enhance financial operations, evidenced by his successful leadership in IPO preparations and ERP migrations. With a global perspective, having worked across North America, Europe, and Asia-Pacific, he brings a unique understanding of international finance dynamics. Michael is a certified CPA (inactive) and holds an MBA from the University of Louisiana at Lafayette, demonstrating his commitment to continuous professional development. His forward-thinking approach positions finance as a strategic partner in business growth.
Michael`s contact details
******@recormedical.com
Colleagues
Vice President Human Resources
Vice President of Sales - East
Vice President Therapy Development
Vice President of Sales, West
Vice President Operations
Vice President Medical Affairs
VP and General Counsel
VP of R&D
Vice President, Therapy Development